LEUPROLIDE\NORETHINDRONE: 57 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
57
Total FAERS Reports
1 (1.8%)
Deaths Reported
7
Hospitalizations
57
As Primary/Secondary Suspect
Active Ingredient: LEUPROLIDE ACETATE\NORETHINDRONE ACETATE ·
First Report: 2011 · Latest Report: 20230601
What Are the Most Common LEUPROLIDE\NORETHINDRONE Side Effects?
#1 Most Reported
Drug ineffective
9 reports (15.8%)
#2 Most Reported
Endometriosis
8 reports (14.0%)
#3 Most Reported
Arthralgia
7 reports (12.3%)
All LEUPROLIDE\NORETHINDRONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 9 | 15.8% | 0 | 0 |
| Endometriosis | 8 | 14.0% | 0 | 0 |
| Arthralgia | 7 | 12.3% | 0 | 1 |
| Hot flush | 6 | 10.5% | 0 | 1 |
| Nausea | 6 | 10.5% | 0 | 0 |
Who Reports LEUPROLIDE\NORETHINDRONE Side Effects? Age & Gender Data
Gender: 98.0% female, 2.0% male. Average age: 33.1 years. Most reports from: US. View detailed demographics →
Is LEUPROLIDE\NORETHINDRONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 1 | 0 | 0 |
| 2014 | 1 | 0 | 1 |
| 2015 | 3 | 0 | 1 |
| 2016 | 2 | 0 | 0 |
| 2017 | 8 | 0 | 0 |
| 2018 | 11 | 0 | 2 |
| 2019 | 5 | 0 | 0 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 1 | 0 |
| 2023 | 1 | 0 | 1 |
What Is LEUPROLIDE\NORETHINDRONE Used For?
| Indication | Reports |
|---|---|
| Endometriosis | 39 |
| Product used for unknown indication | 8 |
Official FDA Label for LEUPROLIDE\NORETHINDRONE
Official prescribing information from the FDA-approved drug label.